These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37004404)

  • 21. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
    Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
    Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cumambrin A prevents OVX-induced osteoporosis
    Zhou L; Liu Q; Hong G; Song F; Zhao J; Yuan J; Xu J; Tan RX; Tickner J; Gu Q; Xu J
    FASEB J; 2019 Jun; 33(6):6726-6735. PubMed ID: 30807230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.
    Hsiao HB; Wu JB; Lin WC
    BMC Complement Altern Med; 2017 May; 17(1):245. PubMed ID: 28468652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Osteoporotic Effects of
    Lim HJ; Park EJ; Won YS; Bak SG; Cheong SH; Lee SW; Lee S; Lee SJ; Rho MC
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiaplakortone B attenuates RANKL-induced NF-κB and MAPK signaling and dampens OVX-induced bone loss in mice.
    Wang Q; Chen D; Wang Y; Dong C; Liu J; Chen K; Song F; Wang C; Yuan J; Davis RA; Kuek V; Jin H; Xu J
    Biomed Pharmacother; 2022 Oct; 154():113622. PubMed ID: 36081291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin Inhibits Osteoclastogenesis and Bone Loss in Ovariectomized Mice by Regulating PRMT1-Mediated Signaling.
    Choi JH; Jang AR; Park MJ; Kim DI; Park JH
    Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33713122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shikonin relieves osteoporosis of ovariectomized mice by inhibiting RANKL-induced NF-κB and NFAT pathways.
    Chen Y; Xie Z; Zhang Y; Xia C; Yang M; Hu X
    Exp Cell Res; 2020 Sep; 394(1):112115. PubMed ID: 32473224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.
    Wu G; Pan L; Sun J; Chen G; Wang S
    Menopause; 2019 Jul; 26(7):785-792. PubMed ID: 31083022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways.
    Qin Y; Song D; Liao S; Chen J; Xu M; Su Y; Lian H; Peng H; Wei L; Chen K; Xu J; Zhao J; Liu Q
    Biomed Pharmacother; 2023 Apr; 160():114347. PubMed ID: 36746095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway.
    Wu L; Liang J; Li J; Xu Y; Chen J; Su Y; Xian Y; Wei J; Xu J; Zhao J; Liu Q; Yang Y
    Eur J Pharmacol; 2022 May; 923():174908. PubMed ID: 35405113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway.
    Li Y; Zhuang Q; Tao L; Zheng K; Chen S; Yang Y; Feng C; Wang Z; Shi H; Shi J; Fang Y; Xiao L; Geng D; Wang Z
    Cell Prolif; 2022 Oct; 55(10):e13291. PubMed ID: 35708050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathways.
    Wang G; Chen K; Ma C; Wang C; Chen D; He J; Liu Y; Jiang T; Yuan J; Chen L; He W; Xu J
    J Cell Physiol; 2022 Mar; 237(3):1790-1803. PubMed ID: 34796915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation.
    Xu Y; Song D; Lin X; Peng H; Su Y; Liang J; Hai N; Zhao J; Liu Q
    Free Radic Biol Med; 2023 Feb; 196():121-132. PubMed ID: 36649902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anacardic acid inhibits RANKL-induced osteoclastogenesis
    Zhao K; Jia Y; Peng J; Pang C; Zhang T; Han W; Jiang J; Lu X; Zhu J; Qian Y
    FASEB J; 2019 Aug; 33(8):9100-9115. PubMed ID: 31050917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehydrodiconiferyl Alcohol Inhibits Osteoclast Differentiation and Ovariectomy-Induced Bone Loss through Acting as an Estrogen Receptor Agonist.
    Lee W; Ko KR; Kim HK; Lee DS; Nam IJ; Lim S; Kim S
    J Nat Prod; 2018 Jun; 81(6):1343-1356. PubMed ID: 29869503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 4'-Demethylnobiletin and 4'-Demethyltangeretin on Osteoclast Differentiation In Vitro and in a Mouse Model of Estrogen-Deficient Bone Resorption.
    Hirata M; Tominari T; Ichimaru R; Takiguchi N; Tanaka Y; Takatoya M; Arai D; Yoshinouchi S; Miyaura C; Matsumoto C; Ma S; Suzuki K; Grundler FMW; Inada M
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.
    Hsiao HB; Lin H; Wu JB; Lin WC
    Osteoporos Int; 2013 May; 24(5):1663-76. PubMed ID: 23143538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation.
    Wu K; Lin TH; Liou HC; Lu DH; Chen YR; Fu WM; Yang RS
    Osteoporos Int; 2013 Aug; 24(8):2201-14. PubMed ID: 23400250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.
    Zhou L; Liu Q; Yang M; Wang T; Yao J; Cheng J; Yuan J; Lin X; Zhao J; Tickner J; Xu J
    J Bone Miner Res; 2016 May; 31(5):964-74. PubMed ID: 26684711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.